vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）とPREFORMED LINE PRODUCTS CO（PLPC）の財務データ比較。上の社名をクリックして会社を切り替えられます
COLLEGIUM PHARMACEUTICAL, INCの直近四半期売上が大きい（$205.4M vs $173.1M、PREFORMED LINE PRODUCTS COの約1.2倍）。COLLEGIUM PHARMACEUTICAL, INCの純利益率が高く（8.3% vs 4.9%、差は3.4%）。COLLEGIUM PHARMACEUTICAL, INCの前年同期比売上増加率が高い（12.9% vs 3.6%）。COLLEGIUM PHARMACEUTICAL, INCの直近四半期フリーキャッシュフローが多い（$122.4M vs $11.8M）。過去8四半期でCOLLEGIUM PHARMACEUTICAL, INCの売上複合成長率が高い（19.1% vs 10.8%）
コレギウムファーマシューティカルは、乱用抑止機能を持つ革新的な疼痛管理治療薬の開発・販売を専門とする米国の製薬企業です。主に米国市場で慢性疼痛患者向け徐放性鎮痛剤を提供し、一般医療・専門医療現場の医療従事者向けに製品を展開しています。
プリフォームド・ライン・プロダクツ社（PLPC）は、送配電、通信、再生可能エネルギーインフラ分野向けのエンジニアリングハードウェアや部品を設計・製造・供給し、世界各国の事業者にネットワークの信頼性と業務効率を高めるソリューションを提供している。
COLL vs PLPC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $205.4M | $173.1M |
| 純利益 | $17.0M | $8.4M |
| 粗利率 | 62.5% | 29.8% |
| 営業利益率 | 29.6% | 6.8% |
| 純利益率 | 8.3% | 4.9% |
| 売上前年比 | 12.9% | 3.6% |
| 純利益前年比 | 35.3% | -19.3% |
| EPS（希薄化後） | $0.48 | $1.72 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $205.4M | $173.1M | ||
| Q3 25 | $209.4M | $178.1M | ||
| Q2 25 | $188.0M | $169.6M | ||
| Q1 25 | $177.8M | $148.5M | ||
| Q4 24 | $181.9M | $167.1M | ||
| Q3 24 | $159.3M | $147.0M | ||
| Q2 24 | $145.3M | $138.7M | ||
| Q1 24 | $144.9M | $140.9M |
| Q4 25 | $17.0M | $8.4M | ||
| Q3 25 | $31.5M | $2.6M | ||
| Q2 25 | $12.0M | $12.7M | ||
| Q1 25 | $2.4M | $11.5M | ||
| Q4 24 | $12.5M | $10.5M | ||
| Q3 24 | $9.3M | $7.7M | ||
| Q2 24 | $19.6M | $9.4M | ||
| Q1 24 | $27.7M | $9.6M |
| Q4 25 | 62.5% | 29.8% | ||
| Q3 25 | 61.7% | 29.7% | ||
| Q2 25 | 57.7% | 32.7% | ||
| Q1 25 | 54.8% | 32.8% | ||
| Q4 24 | 54.0% | 33.3% | ||
| Q3 24 | 60.8% | 31.1% | ||
| Q2 24 | 62.5% | 31.9% | ||
| Q1 24 | 63.1% | 31.3% |
| Q4 25 | 29.6% | 6.8% | ||
| Q3 25 | 29.7% | 7.4% | ||
| Q2 25 | 18.7% | 10.1% | ||
| Q1 25 | 12.2% | 8.8% | ||
| Q4 24 | 20.9% | 10.5% | ||
| Q3 24 | 21.9% | 7.1% | ||
| Q2 24 | 32.7% | 8.1% | ||
| Q1 24 | 34.1% | 8.2% |
| Q4 25 | 8.3% | 4.9% | ||
| Q3 25 | 15.0% | 1.5% | ||
| Q2 25 | 6.4% | 7.5% | ||
| Q1 25 | 1.4% | 7.8% | ||
| Q4 24 | 6.9% | 6.3% | ||
| Q3 24 | 5.9% | 5.2% | ||
| Q2 24 | 13.5% | 6.8% | ||
| Q1 24 | 19.1% | 6.8% |
| Q4 25 | $0.48 | $1.72 | ||
| Q3 25 | $0.84 | $0.53 | ||
| Q2 25 | $0.34 | $2.56 | ||
| Q1 25 | $0.07 | $2.33 | ||
| Q4 24 | $0.36 | $2.13 | ||
| Q3 24 | $0.27 | $1.54 | ||
| Q2 24 | $0.52 | $1.89 | ||
| Q1 24 | $0.71 | $1.94 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $386.7M | — |
| 総負債低いほど良い | — | $38.3M |
| 株主資本純資産 | $301.7M | $475.5M |
| 総資産 | $1.7B | $653.6M |
| 負債/資本比率低いほどレバレッジが低い | — | 0.08× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — | ||
| Q1 24 | $318.0M | — |
| Q4 25 | — | $38.3M | ||
| Q3 25 | — | $36.0M | ||
| Q2 25 | — | $31.8M | ||
| Q1 25 | — | $29.1M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | — | $27.2M | ||
| Q2 24 | — | $31.6M | ||
| Q1 24 | — | $55.0M |
| Q4 25 | $301.7M | $475.5M | ||
| Q3 25 | $274.8M | $466.3M | ||
| Q2 25 | $232.2M | $460.7M | ||
| Q1 25 | $234.4M | $435.8M | ||
| Q4 24 | $228.8M | $422.3M | ||
| Q3 24 | $234.3M | $429.0M | ||
| Q2 24 | $216.6M | $416.2M | ||
| Q1 24 | $222.2M | $413.4M |
| Q4 25 | $1.7B | $653.6M | ||
| Q3 25 | $1.6B | $644.6M | ||
| Q2 25 | $1.6B | $631.5M | ||
| Q1 25 | $1.6B | $592.5M | ||
| Q4 24 | $1.7B | $573.9M | ||
| Q3 24 | $1.6B | $592.0M | ||
| Q2 24 | $1.1B | $572.6M | ||
| Q1 24 | $1.1B | $586.1M |
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.13× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $123.0M | $21.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $122.4M | $11.8M |
| FCFマージンFCF / 売上 | 59.6% | 6.8% |
| 設備投資強度設備投資 / 売上 | 0.3% | 5.9% |
| キャッシュ転換率営業CF / 純利益 | 7.25× | 2.60× |
| 直近12ヶ月FCF直近4四半期 | $327.6M | $33.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $123.0M | $21.9M | ||
| Q3 25 | $78.4M | $18.9M | ||
| Q2 25 | $72.4M | $26.9M | ||
| Q1 25 | $55.4M | $5.7M | ||
| Q4 24 | $84.6M | $24.1M | ||
| Q3 24 | $-9.0M | $9.4M | ||
| Q2 24 | $67.4M | $28.3M | ||
| Q1 24 | $61.9M | $5.8M |
| Q4 25 | $122.4M | $11.8M | ||
| Q3 25 | $78.3M | $8.3M | ||
| Q2 25 | $72.4M | $18.6M | ||
| Q1 25 | $54.6M | $-5.3M | ||
| Q4 24 | $84.1M | $20.6M | ||
| Q3 24 | $-9.2M | $5.8M | ||
| Q2 24 | $67.1M | $24.6M | ||
| Q1 24 | $61.4M | $1.8M |
| Q4 25 | 59.6% | 6.8% | ||
| Q3 25 | 37.4% | 4.7% | ||
| Q2 25 | 38.5% | 10.9% | ||
| Q1 25 | 30.7% | -3.6% | ||
| Q4 24 | 46.2% | 12.3% | ||
| Q3 24 | -5.8% | 3.9% | ||
| Q2 24 | 46.2% | 17.7% | ||
| Q1 24 | 42.3% | 1.3% |
| Q4 25 | 0.3% | 5.9% | ||
| Q3 25 | 0.1% | 6.0% | ||
| Q2 25 | 0.0% | 4.9% | ||
| Q1 25 | 0.4% | 7.4% | ||
| Q4 24 | 0.3% | 2.1% | ||
| Q3 24 | 0.2% | 2.4% | ||
| Q2 24 | 0.2% | 2.7% | ||
| Q1 24 | 0.4% | 2.8% |
| Q4 25 | 7.25× | 2.60× | ||
| Q3 25 | 2.49× | 7.21× | ||
| Q2 25 | 6.05× | 2.12× | ||
| Q1 25 | 22.92× | 0.49× | ||
| Q4 24 | 6.75× | 2.30× | ||
| Q3 24 | -0.96× | 1.22× | ||
| Q2 24 | 3.44× | 3.02× | ||
| Q1 24 | 2.23× | 0.60× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
